Monitoring Brain Activity During Heart Rhythm Treatment
Part of Heart & circulation clinical trials.
This trial compares two ways of giving sedation (sleepy medicine) during a procedure to restore normal heart rhythm in people with atrial fibrillation. One method uses a special brain monitor to guide sedation doses, while the other uses standard clinical judgment. The goal is to see if the brain monitor helps keep you safer and more comfortable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have atrial fibrillation (irregular heartbeat) and need an elective electrical cardioversion (shock treatment to restore normal rhythm)
- Your heart function is adequate (left ventricular ejection fraction ≥30%)
- You have received proper blood-thinning medication or have no clot risk in your heart
- You can safely receive propofol and fentanyl (common sedation medicines) without allergies
- You are in stable condition without severe heart, lung, liver, or kidney problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares deep sedation methods during catheter ablation for atrial fibrillation. It aims to find which sedation approach is safer and more comfortable for people with AF who have not had this procedure before.
This trial tests a streamlined sedation approach during pulsed-field ablation, a newer technique to treat irregular heartbeat (atrial fibrillation). Researchers want to confirm it's safe and practical.
This study compares two ways to keep you comfortable during a minimally invasive procedure to treat irregular heartbeats (atrial fibrillation): lighter sedation where you're drowsy but responsive, versus deeper anesthesia where you're fully asleep. The goal is to see which approach is safer and works better for a newer ablation technique called pulsed-field ablation.
This trial compares two sedation methods during a procedure to restore normal heart rhythm in patients with atrial fibrillation. It tests whether a cardiologist can safely give one sedative (midazolam) instead of requiring an anesthesiologist with a different sedative (propofol).
This trial compares two sedative medicines (remimazolam and propofol) given during heart ablation procedures. The study uses brain-wave monitoring to see which medicine provides better sedation and recovery. It's for people who are already scheduled for this procedure with a specific doctor.
This trial tests a mild sedation method using remimazolam and fentanyl during a procedure called pulsed-field ablation for atrial fibrillation (afib). It aims to find a safe and effective way to keep you comfortable without deep sedation.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.